The role of SOX2 in promoting resistance to AR-targeted therapies in prostate cancer

被引：1
|
作者：
de Wet, Larischa [1 ]
Williams, Anthony [1 ]
Gillard, Marc [1 ]
Kregel, Steve [2 ]
Garcia, Tzintzuni [1 ]
McAuley, Erin [1 ]
Brown, Ryan [1 ]
Vander Griend, Donald [1 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-3348
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3348
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Arabilin overcomes resistance to AR-targeted therapy
    Takahiro Fujimaki
    Shun Saito
    Masaya Imoto
    The Journal of Antibiotics, 2017, 70 : 328 - 330
  • [2] AKR1C3 Promotes AR-V7 Protein Stabilization and Confers Resistance to AR-Targeted Therapies in Advanced Prostate Cancer
    Liu, Chengfei
    Yang, Joy C.
    Armstrong, Cameron M.
    Lou, Wei
    Liu, Liangren
    Qiu, Xiaomin
    Zou, Binhao
    Lombard, Alan P.
    D'Abronzo, Leandro S.
    Evans, Christopher P.
    Gao, Allen C.
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (10) : 1875 - 1886
  • [3] Arabilin overcomes resistance to AR-targeted therapy
    Fujimaki, Takahiro
    Saito, Shun
    Imoto, Masaya
    JOURNAL OF ANTIBIOTICS, 2017, 70 (03): : 328 - 330
  • [4] The molecular pathogenesis of SOX2 in prostate cancer
    Liu, Shixue
    Yu, Honglian
    Zhao, Zhankui
    DISCOVER ONCOLOGY, 2025, 16 (01)
  • [5] Targeting resistance mechanisms to AR-targeted therapy in prostate cancer through inhibition of CREBBP/EP300
    Dougherty, Bonnie V.
    Thomas, Beatrice C.
    Walsh, Alice M.
    Calvo, Veronica
    Ware, Kathryne E.
    Armstrong, Andrew J.
    Renstrup, Jens
    Somarelli, Jason A.
    Schadt, Eric E.
    CANCER RESEARCH, 2024, 84 (06)
  • [6] Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer
    Li, Xiaoling
    Wang, Yunguan
    Deng, Su
    Zhu, Guanghui
    Wang, Choushi
    Johnson, Nickolas A.
    Zhang, Zeda
    Tirado, Carla Rodriguez
    Xu, Yaru
    Metang, Lauren A.
    Gonzalez, Julisa
    Mukherji, Atreyi
    Ye, Jianfeng
    Yang, Yuqiu
    Peng, Wei
    Tang, Yitao
    Hofstad, Mia
    Xie, Zhiqun
    Yoon, Heewon
    Chen, Liping
    Liu, Xihui
    Chen, Sujun
    Zhu, Hong
    Strand, Douglas
    Liang, Han
    Raj, Ganesh
    He, Housheng Hansen
    Mendell, Joshua T.
    Li, Bo
    Wang, Tao
    Mu, Ping
    CANCER CELL, 2023, 41 (08) : 1427 - +
  • [7] ZNF397 Deficiency Triggers TET2-Driven Lineage Plasticity and AR-Targeted Therapy Resistance in Prostate Cancer
    Xu, Yaru
    Yang, Yuqiu
    Wang, Zhaoning
    Sjostrom, Martin
    Jiang, Yuyin
    Tang, Yitao
    Cheng, Siyuan
    Deng, Su
    Wang, Choushi
    Gonzalez, Julisa
    Johnson, Nickolas A.
    Li, Xiang
    Li, Xiaoling
    Metang, Lauren A.
    Mukherji, Atreyi
    Xu, Quanhui
    Tirado, Carla R.
    Wainwright, Garrett
    Yu, Xinzhe
    Barnes, Spencer
    Hofstad, Mia
    Chen, Yu
    Zhu, Hong
    Hanker, Ariella B.
    Raj, Ganesh V.
    Zhu, Guanghui
    He, Housheng H.
    Wang, Zhao
    Arteaga, Carlos L.
    Liang, Han
    Feng, Felix Y.
    Wang, Yunguan
    Wang, Tao
    Mu, Ping
    CANCER DISCOVERY, 2024, 14 (08) : 1496 - 1521
  • [8] Genomic loss of TP53 impairs AR-targeted activity in metastatic prostate cancer
    Han, Wanting
    Nyquist, Michael D.
    Coleman, Ilsa
    De Sarkar, Navonil
    Ang, Lisa
    Corey, Eva
    Nelson, Peter S.
    CANCER RESEARCH, 2023, 83 (11)
  • [9] Paradoxical role of SOX2 in gastric cancer
    Carrasco-Garcia, Estefania
    Santos, Juliana C.
    Garcia, Idoia
    Brianti, Mitsue
    Garcia-Puga, Mikel
    Pedrazzoli, Jose, Jr.
    Matheu, Ander
    Ribeiro, Marcelo L.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2016, 6 (04): : 701 - 713
  • [10] The role of SOX2 in angiogenesis in breast cancer
    Wang, Hui
    Xie, Jun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (05): : 2805 - 2810
12345